In high-fat diet-induced models of obesity and MASLD, SRT1720 upregulates PGC-1 and PPAR expression, promoting fatty acid -oxidation and reducing hepatic triglyceride levels
Studies have found ways that people can reduce or prevent weight gain and even continue to lose weight after stopping a GLP-1
8% fewer CV events 7% fewer hospitalisations 7% fewer bed days than a glucose management approach GBP ~1.68 billion in UK cost savings by 2040
By activating these receptors, Mounjaro helps reduce hunger, slows the emptying of food from the stomach, and enhances the body's ability to manage glucose levels, ultimately leading to sustained weight loss
10.1186/1471-2202-6-3 2 AlaimoA.GorojodR
Genetic data should be combined with your clinical history (prior IBS, medication sensitivities), current medications, and provider assessment